To make an appointment, please call 1-800-KARMANOS (1-800-527-6266) or request an appointment online
As a leader in cancer research, Karmanos is able to offer patients access to innovative treatments and clinical trials that are often times not available anywhere else.
To offer hope and longer life to patients with all types of cancer, Karmanos offers the latest types of therapy through our clinical trials program. Through clinical trials, we are creating new knowledge about how therapies fight cancer and provide national leadership in testing these new therapies.
We understand that cancer is a complex disease that demands complex care. We provide each patient with a dynamic, carefully constructed treatment plan focused on their specific cancer and their unique needs.
We listen to you to design a plan that provides you with respect, compassionate care and is responsive to your emotional and practical concerns.
To offer hope and longer life to patients with all types of cancer, Karmanos offers the latest types of therapy through our Clinical Trials Program.
Karmanos’ Phase 1 Clinical Trials Multidisciplinary Team conducts clinical research studies with new, investigational cancer drugs.
Phase 1 trials are the first stage of clinical trials in the careful process of developing new cancer treatments. A typical Phase 1 clinical trial evaluates how a new drug should be given, either orally or injected into the blood, how often, and what dosage is safe. A Phase I trial is often the first time a drug has been given to human, or the first time a new drug has been given to a human in combination with another standard cancer treatment.
Each patient receives personal attention from the Phase 1 Team. All patients considered for a Phase 1 clinical trial must go through an initial screening consultation to determine if they are eligible for a research study and if a clinical trial is their best treatment option. Once it is determined if they are eligible, patients will go to our dedicated Phase I clinic, Eisenberg Center for Translational Therapeutics, within the Karmanos Cancer Center in Detroit for their appointments.
Patient safety and care are our top priorities. Phase 1 Team physicians, nurse practitioners and physician assistants monitor patients carefully for any changes in their condition and will maintain close contact with referring physicians. Patients may opt-out of a clinical trial at any time.
Here’s what patients can expect from our Phase 1 Clinical Trials Multidisciplinary Team:
"If someone comes to Karmanos first and then goes to get a second opinion, they’re going to come back to Karmanos." Terrell Thomas has always been...
Leslie Cameron Devereaux was born on Oct. 2, 1942, to Adelyn Brockway and Richard (Dick) C. Devereaux. She spent summers and winters at the family...
WDIV Like many people during the pandemic, Nikoa Dean’s annual mammogram was canceled. It was when she felt a pain in her chest months later that ...